| |
 |
|
Class Information
Number: 424/133.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Structurally-modified antibody, immunoglobulin, or fragment thereof (e.g., chimeric, humanized, cdr-grafted, mutated, etc.)
Description: Subject matter involving an antibody, immunoglobulin, or fragment thereof that is purposely altered with respect to its amino acid sequence or glycosylation, or with respect to its composition of heavy and light chains or immunoglobulin regions or domains, as compared with that found in nature; or wherein the antibody, immunoglobulin, or fragment thereof is part of a larger, synthetic protein.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7618631 |
Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs |
Nov. 17, 2009 |
| 7615616 |
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
Nov. 10, 2009 |
| 7615219 |
Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia |
Nov. 10, 2009 |
| 7615218 |
Methods for determining and lowering caffeine concentration in fluids |
Nov. 10, 2009 |
| 7615217 |
Artificial proteins with reduced immunogenicity |
Nov. 10, 2009 |
| 7615216 |
Antibodies against CCR5 and uses thereof |
Nov. 10, 2009 |
| 7615215 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615214 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615213 |
Antibodies against human interleukin-13 and pharmaceutical compositions thereof |
Nov. 10, 2009 |
| 7612179 |
antibodies binding to a C-terminal fragment of apoliopoprotein E |
Nov. 3, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7611707 |
Glycoprotein VI antibodies and methods thereof |
Nov. 3, 2009 |
| 7611705 |
Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases |
Nov. 3, 2009 |
| 7608694 |
Antibody molecules having specificity for human IL-1.beta. |
Oct. 27, 2009 |
| 7608260 |
Stabilized immunoglobulins |
Oct. 27, 2009 |
| 7605233 |
Tumour necrosis factor binding ligands |
Oct. 20, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7601818 |
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
Oct. 13, 2009 |
| 7601817 |
Antibody peg positional isomers, compositions comprising same, and use thereof |
Oct. 13, 2009 |
| 7597893 |
Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of Pseudomonas aeruginosa |
Oct. 6, 2009 |
| 7597890 |
Methods and compositions for diagnosing lung cancer |
Oct. 6, 2009 |
| 7597889 |
Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
Oct. 6, 2009 |
| 7597888 |
Glycoprotein VI and uses thereof |
Oct. 6, 2009 |
| 7597887 |
KIM-1 antagonists and use to modulate immune system |
Oct. 6, 2009 |
| 7597886 |
Tumor necrosis factor-gamma |
Oct. 6, 2009 |
| 7595051 |
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
Sep. 29, 2009 |
| 7595047 |
Compositions and methods for promoting or inhibiting angiogenesis |
Sep. 29, 2009 |
| 7595046 |
Treatment of cancer using anti-Apo-2 antibodies |
Sep. 29, 2009 |
| 7592427 |
Antibodies to IL-21 receptor |
Sep. 22, 2009 |
| 7592007 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
Sep. 22, 2009 |
| 7592006 |
Composition comprising the LO-CD2a antibody |
Sep. 22, 2009 |
| 7589181 |
Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use |
Sep. 15, 2009 |
| 7585953 |
Antibodies specific for TAT285-1 |
Sep. 8, 2009 |
| 7585505 |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
Sep. 8, 2009 |
| 7585503 |
Method for detecting multi-drug resistance |
Sep. 8, 2009 |
| 7585500 |
Fully human monoclonal antibodies to IL-13 |
Sep. 8, 2009 |
| 7582736 |
Prostate cancer specific internalizing human antibodies |
Sep. 1, 2009 |
| 7582735 |
Feline immunoglobulin E molecules and related methods |
Sep. 1, 2009 |
| 7582296 |
Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
Sep. 1, 2009 |
| 7579446 |
Binding molecules capable of neutralizing rabies virus and uses thereof |
Aug. 25, 2009 |
| 7579000 |
Tissue factor targeted antibodies as anticoagulants |
Aug. 25, 2009 |
| 7576189 |
Antibodies to human vascular endothelial growth factor 2 and methods of using the same |
Aug. 18, 2009 |
| 7572456 |
Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereof |
Aug. 11, 2009 |
| 7572445 |
Peptides for detection of antibody to porcine reproductive respiratory syndrome virus |
Aug. 11, 2009 |
| 7572444 |
Binding proteins specific for human matriptase |
Aug. 11, 2009 |
| 7569674 |
Autophilic antibodies |
Aug. 4, 2009 |
| 7569673 |
Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
Aug. 4, 2009 |
| 7569364 |
Anti-NGF antibodies and methods using same |
Aug. 4, 2009 |
| 7563882 |
Polynucleotides encoding antibodies that bind to the C35 polypeptide |
Jul. 21, 2009 |
|
|
|
